[The effect of Wobenzym on the atherogenic potential and inflammatory factors at the rehabilitation stage for patients who have had a myocardial infarct].
Effects were studied of wobenzyme on atherogenicity of blood serum and immunoinflammatory reactions in patients with myocardial infarction during the rehabilitation stage over six months. The basis therapy when supplemented with wobenzyme was found out to facilitate normalization of the atherogenic potential and to have a positive action on the mediators of the inflammatory process.
Riabokon'
E N
EN
Gavrilenko
T I
TI
Kornilina
E M
EM
Iakushko
L V
LV
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D001161:Arteriosclerosis / Q000097:blood / Q000276:immunology / Q000517:prevention & control*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D006801:Humans; D006867:Hydrolases / Q000627:therapeutic use*; D018836:Inflammation Mediators / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000276:immunology / Q000534:rehabilitation*; D012431:Rutin / Q000627:therapeutic use*; D013997:Time Factors
D000276:Adjuvants, Immunologic; D004338:Drug Combinations; D018836:Inflammation Mediators; D012431:Rutin; C023295:Wobenzym; D006867:Hydrolases